Table 2.
Antibiotics | Resistance rates (in %) | p | ||
---|---|---|---|---|
Total (n = 441) | ICUs (n = 242) | other units (n = 199) | ||
Ticarcillin | 89,00 | 98,3 | 75,46 | p< 0.001 |
Piperacillin | 87,56 | 97,85 | 72,84 | p< 0.001 |
Ticarcilline/ clavulanic acide | 87,41 | 95,7 | 76,23 | p< 0.001 |
Piperacillin/Tazobactam | 79,15 | 90,7 | 61,15 | p< 0.001 |
Ceftazidime | 86,03 | 95,8 | 72,12 | p< 0.001 |
Cefepime | 86,17 | 94,66 | 73,76 | p< 0.001 |
Imipenem | 76,19 | 87,7 | 59,51 | p< 0.001 |
Tobramycin | 43,03 | 44 | 30,91 | p< 0.001 |
Amikacin | 52,28 | 59,3 | 42,33 | p = 0,027 |
Netilmicin | 33,07 | 38,4 | 25,16 | p = 0,033 |
Ciprofloxacin | 87,78 | 96,6 | 75,00 | p< 0.001 |
Sulfaméthoxazole/Trimetoprim | 78,96 | 87,3 | 66,88 | p< 0.001 |
Colistin | 1,7 | 1,68 | 1,79 | p = 0,869 |
Tetracycline | 90,89 | 93,53 | 87,12 | p = 0,146 |
Rifampicin | 32,11 | 34,3 | 28,97 | p = 0,403 |
MDR rate | 77,5 | 92,6 | 75,3 | p< 0.001 |